Streptococcal toxic shock syndrome

References

• Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14: 2–11.
   PubMed Web of Science ®Google Scholar
• Stevens DL. 1992. Streptococcal toxic shock syndrome. Infect Med 1992; 9: 33–9.
   Google Scholar
• Stevens DL. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 2000; 51: 271–88.
   PubMed Web of Science ®Google Scholar
• Stevens DL, Tanner MH, Winship J, et al. Severe Group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1–7.
   PubMed Web of Science ®Google Scholar
• Wheeler MC, Roe MH, Kaplan EL, et al. Outbreak of Group A streptococcus septicaemia in children. Clinical, epidemiologic and microbiological correlates. JAMA 1991; 266: 533–7.
   Google Scholar
• Kohler W. Streptococcal toxic shock syndrome. Int I Med Microbiol Virol Parasitol Infect Dis 1990; 272: 257–64.
   Web of Science ®Google Scholar
• Stevens DL. Streptococcal toxic shock syndrome: spectrum of disease, pathogenesis and new concepts in treatment. Emerg Infect Dis 1995; 1: 69–78.
   PubMed Web of Science ®Google Scholar
• Fast DJ, Schlievert PM, Nelson RD. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 1989; 57: 291–4.
   Google Scholar
• Hackett SP, Schlievert PM, Stevens DL. Cytokine production by human mononuclear cells in response to streptococcal exotoxins. Clin Res 1991; 39: 189–92.
   Google Scholar
• Stevens DL. The flesh-eating bacterium: what's next? J Infect Dis 1999; 179 (suppl. 2): S366–74.
   Google Scholar
• Lancefield RC. Current knowledge of type specific M antigens of group A streptococci. I Immunol 1962; 89: 307–13.
   PubMed Web of Science ®Google Scholar
• Mollick JA, Rich RR. Characterization of a super-antigen from a pathogenic strain of streptococcus pyogenes. Clin Res 1991; 39: 213–15.
   Google Scholar
• Watanabe-Ohnishi R, Low DE, McGeer A, et al. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome, Ontario Streptococcal Study Project. I Infect Dis 1995; 171: 74–84.
   Google Scholar
• Muller-Alouf H, Alouf JE, Gerlach D, et al. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci and lipopolysaccharide. Infect Immun 1994; 62: 4915–21.
   Google Scholar
• Stevens DL. Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J 1994; 13: 561–6.
   PubMed Web of Science ®Google Scholar
• Adams EM, Gudmundsson S, Yocum DE, et al. Streptococcal myositis. Arch Intern Med 1985; 145: 1020–3.
   PubMed Web of Science ®Google Scholar
• Stevens DL. Streptococcal Infections of skin and soft tissues. In Stevens, DL, Mandell, GL (Eds), Atlas of Infectious Diseases, II: 3.1-3.11. Philadelphia: Churchill Livingstone, 1995.
   Google Scholar
• Pfanner W. Zur Kenntnis und Behandlung des nekro-tisierenden Erysipels. Dtsch Z Chir 1918; 144: 108–12.
   Google Scholar
• Meleney FL. Hemolytic streptococcus gangrene. Arch Surg 1924; 9: 317–64.
   Google Scholar
• Svane S. Peracute spontaneous streptococcal myositis. A report on 2 fatal cases with review of the literature. Acta Chir Scand 1971; 137: 155–63.
   PubMedGoogle Scholar
• Eagle H. Experimental approach to the problem of treatment failure with penicillin in Group A streptococcal infection in mice. Am J Med 1952; 13: 389–99.
   PubMed Web of Science ®Google Scholar
• Gatanaduy AS, Kaplan EL, Huwe BB, et al. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980; 2: 498–502.
   PubMed Web of Science ®Google Scholar
• Hribalova V. Streptococcus pyogenes and the toxic shock syndrome. Ann Intern Med 1988; 108: 772–8.
   PubMed Web of Science ®Google Scholar
• Stevens DL, Yan S, Bryant AE. Penicillin binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation of the inoculum effect. J Infect Dis 1993; 167: 1401–5.
   Google Scholar
• Stevens DL, Maier KA, Mitten JE. Effects of antibiotics on toxin production and viability of Clostridium Perfringens. Antimicrob. Agents Chemother 1987; 31: 213–18.
   PubMedGoogle Scholar
• Gemmell CG, Peterson PK, Schmeling D, et al. Potentiation of opsonisation and phagocytosis of Streptococcus Pyogenes following growth in the presence of clindamycin. J Clin Invest 1981; 67: 1249–56.
   PubMed Web of Science ®Google Scholar
• Stevens DL, Bryant AE, Hackett SP. Antibiotic effect on bacterial viability, toxin production and host response. Clin Infect Dis 1995; 20 (suppl. 2): S154–7.
   Google Scholar
• McHenry CR. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 1995; 221: 558–65.
   PubMed Web of Science ®Google Scholar
• Risemann JF. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 1990; 108: 847–50.
   PubMed Web of Science ®Google Scholar
• Bary W, Hudgins L, Donta S, et al. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 1992; 267: 3315–16.
   PubMed Web of Science ®Google Scholar
• Young JM. Necrotising fasciitis. Lancet 1994; 343: 1427–30.
   Google Scholar
• Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. Clin Infect Dis 1999; 28: 800–7.
   Google Scholar